ARCHIVES

Aggressive, Tailored Therapy Improves Survival, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | October 31, 2008

Download PDF Visit The Full Archive

Related Articles

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

NCI Plans For Research In Breast, Prostate Cancer, Drafted

January 28, 1994

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

MammoSite Radiation System Delivers Dose To Target Tissue

February 28, 2003

In Brief: Two New Section Chiefs Named In NCI Research Contracts Branch; S. 988 Markup Set For April 25

April 18, 1980